Package 50090-4749-0
Brand: bupropion hydrochloride
Generic: bupropion hydrochloridePackage Facts
Identity
Package NDC
50090-4749-0
Digits Only
5009047490
Product NDC
50090-4749
Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4749-0)
Marketing
Marketing Status
Brand
bupropion hydrochloride
Generic
bupropion hydrochloride
Sample Package
No
Linked Drug Pages (0)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8848d8d9-7ef9-49e9-9f04-44458b16c5b4", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["a0fdfc21-165a-43fa-9b3c-e48f3b892250"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4749-0)", "package_ndc": "50090-4749-0", "marketing_start_date": "20191122"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4749-1)", "package_ndc": "50090-4749-1", "marketing_start_date": "20191122"}], "brand_name": "Bupropion Hydrochloride", "product_id": "50090-4749_8848d8d9-7ef9-49e9-9f04-44458b16c5b4", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-4749", "generic_name": "Bupropion Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20170614", "listing_expiration_date": "20261231"}